19–32 mAb stained not only CD26-positive tumor cell line specimens, but also those from CD26-negative tumor cell lines as well, strongly suggesting that it is inappropriate for the detection of denatured CD26 expression in FFPE clinical tumor samples. Here, DPP4 is linked to neoplasm.